The minor alleles of 3 FOXO3 single nucleotide polymorphisms (SNPs)-rs2802292, rs2253310, and rs2802288-are associated with human longevity. The aim of the present study was to test these SNPs for association with blood pressure (BP) and essential hypertension (EHT).
The forkhead box-O3 (FoxO3) gene (FOXO3) codes for an evolutionarily conserved transcription factor in the insulin signaling pathway. FoxO3 is recognized in model organisms for its ability to protect against environmental and other biological stressors and thereby enhance lifespan. 1 FoxO3 controls expression of multiple downstream genes whose products affect diverse processes involved in aging and agerelated diseases (e.g., energy metabolism, oxidative stress, inflammation, apoptosis, and the cell cycle). [2] [3] [4] In a study of American men of Japanese ancestry, we were the first to report an association of 3 single nucleotide polymorphisms (SNPs) in FOXO3 (chromosome 6q21) with longevity, the strongest being rs2802292. 5 Eleven independent studies of populations of diverse ancestry then confirmed and extended these findings. A meta-analysis confirmed the minor (G) allele of rs2802292 as exhibiting the strongest association with longevity in men (odds ratio, 1.54; 95% confidence intervals, 1.33-1.67). 6 A meta-analysis of genomewide association studies of this SNP yielded an odds ratio of 1.17 (P = 1.9 × 10 -10 ). 7 The rs2802292 G allele has a stronger effect on longevity in Asians than Europeans. 8 The longevity-associated SNPs were located in or near intron 2 of FOXO3. [9] [10] [11] Our extensive sequencing analyses have ruled out involvement of coding region variation, 11 suggesting that the causative variant(s) may affect FOXO3 expression. Understanding the disease-specific protection that enhances lifespan may reveal biological targets for future therapies that could help ameliorate aging-related diseases and thereby confer healthier aging.
FoxO3 and the sirtuin family of NAD + -dependent deacetylases have been implicated in protection against chronic conditions of aging. 3, 5, [12] [13] [14] [15] This includes cardiovascular disease, with FoxO proteins being able to regulate a number of specific intracellular pathways in the vascular wall and heart. 16 These pathways have implications for hypertension.
We hypothesized that the protective effect of longevityassociated alleles of FOXO3 is mediated in part by protection against blood pressure (BP) elevation and thus the prevalence of essential hypertension (EHT). Since EHT is a major age-associated risk factor for cardiovascular death, 17 such an effect might explain, at least in part, the association of the FOXO3 variants with attainment of extreme old age. The aim of the present study was to determine whether there is a genetic association of longevity-associated alleles of our FOXO3 SNPs with lower BP and EHT.
METHODS

Study population
The primary study involved American subjects of Japanese ancestry living on Oahu and other islands of Hawaii. This cohort was part of the multiracial Stanford Asia and Pacific Program for Hypertension and Insulin Resistance (SAPPHIRe) cohort within the Family Blood Pressure Program (FBPP II 18 ; http://clinicaltrials.gov/ct2/show/record/ NCT00005270?term=FBPP&rank=3). Unlike other cohorts, the particular population used was relatively homogeneous with regard to geographical finding of genetic associations, should any exist. The characteristics of these subjects have been described in a previous molecular genetic study of EHT. 19 The present study involved 843 subjects after exclusion of 1 of 844 subjects genotyped but lacking BP data. All subjects were offspring of participants of the Honolulu Heart Program, which consisted of unselected American men who self-reported as having Japanese ancestry and who were recruited in 1965-1968. 20 All 4 grandparents of each of the FBPP subjects were therefore of Japanese ancestry. The participants were from 461 families in which 233 families had a single participant, 122 families had two participants, 68 three, 32 four, 4 five, 1 six, and 1 eight. Logistic models with generalized estimating equations were used to adjust for age and sibling correlation to reduce any cluster effect arising from familial relationships. Exclusion criteria for the current study were: treatment for cancer by chemotherapy or radiation within the past 6 months, clinical diagnosis of other chronic disease, pregnancy and having given birth within the past 6 months. We analyzed 432 male subjects aged 56.7 ± 6.6 SD (range 40-75) years and 411 female subjects aged 56.6 ± 6.5 (range 39-77) years.
Procedures performed were in accord with institutional guidelines and were approved by the Institutional Review Board of Kuakini Medical Center. Written informed consent was obtained from all study participants or from family representatives, if participants could not provide consent.
Blood pressure measurement
BP was measured using the Dinamap automated BP reading device. Three separate readings were taken over a period spanning 1 minute and the means of the readings for systolic and diastolic BP were computed for each subject. Subjects were considered to have EHT if their systolic/diastolic BP was ≥140/≥90 mm Hg, or they were receiving antihypertensive medication subsequent to an initial diagnosis of EHT. The normotensive group of subjects had a systolic/diastolic BP reading of <140/<90 mm Hg and were not taking antihypertensive medication.
Genotyping
DNA was isolated from the buffy coat of peripheral blood using the PureGene system (Gentra Systems, Minneapolis, MN) and quantified using PicoGreen staining (Molecular Probes, Eugene, OR). We selected 3 SNPs (rs2802288, rs2253310, and rs2802292; minor allele frequencies in Japanese HapMap samples (MAF) = 0.280, 0.244, and 0.239, respectively) that represented the strongest associations with longevity within intron 2 of FOXO3 we found previously. 5 Genotyping involved an allelic discrimination assay, TaqMan (Applied Biosystems, Foster City, CA), as performed on a Life Technologies (Carlsbad, CA) QuantStudio 12K Flex OpenArray system. All positive controls on each genotyping plate were evaluated for consistency. We have found that these methods are exceptionally robust, have an accuracy of >99.9% on retesting, and a success rate of 99.6% (data not shown).
Statistical analyses
The study had >80% power to detect genotypic association at the P = 0.05 level. Pairwise linkage disequilibrium 
Replication studies
Association of rs2802292 genotypes with hypertension in the SONIC (Septuagenarians, Octogenarians, Nonagenarians Investigation with Centenarians) study 22 of Japanese subjects aged 80 ± 1 years from Hyogo and Tokyo was tested. In this study genotyping involved the TaqMan method. 23 In addition, data for each of the 3 FOXO3 SNP obtained from a meta-analysis of genome-wide association studies of systolic and diastolic BP in subjects of European descent were examined. 24 
RESULTS
Demographic parameters for each FOXO3 genotype
The 3 SNPs were in strong linkage disequilibrium (Supplementary Table S1 ). As a result, demographic parameters were similar for genotypes of each SNP. Table 1 shows physiological and clinical phenotypes for rs2802292 genotypes in female and male subjects adjusting for sibling relatedness and age and Supplementary Tables S2  and S3 show these results for rs2253310 and rs2802288. In women, lower systolic and diastolic BP, as well as EHT prevalence, were associated with the minor allele of each SNP. No such association was seen in men or all subjects combined. Glucose at 1 h = blood glucose 1 hour after ingestion of oral Glucola glucose load. Insulin at 1 h = insulin hour after oral Glucola glucose load. Glucose at 2 h = blood glucose 2 hours after ingestion of oral Glucola glucose load. Insulin at 2 h = insulin 1 hour after oral Glucola glucose load.
Significant P values are shown in bold.
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; BP, blood pressure. a T = major allele and G = minor allele of rs2802292. b After correction for multiple comparisons by the Bonferroni method all P < 0.05 values became nonsignificant (P > 0.05). Significant P values are shown in bold.
Association of genotype with essential hypertension
No significant association of FOXO3 genotype with EHT was seen for all subjects or for men, but for women, χ 2 analysis showed a significant association of FOXO3 genotype with EHT ( Table 2 ). The frequency of minor allele homozygotes in EHT vs. normotensive female subjects was 3.3% vs. 9.6%, 3.9% vs. 9.6% and 3.3% vs. 9.5% for rs2802292, rs2253310, and rs2802288, respectively. Haplotype χ 2 analysis of data for the 3 SNPs gave P = 0.0002 for women (which remained significant after correction for multiple testing), P = 0.031 for all subjects and P = 0.29 for men. The minor allele was protective against EHT after adjusting for age, and using logistic models with generalized estimating equations to adjust for any cluster effect arising from the inclusion of subjects who were siblings (Table 3) . No difference was found between pre-and postmenopausal women.
Association of genotype with BP in hypertensive and normotensive subjects
Since BP was affected by antihypertensive medication in EHT subjects, data for these are not shown. For normotensive subjects the longevity-associated minor allele of each FOXO3 SNP was associated with lower systolic and diastolic BP in women but not in men or all subjects combined using a stratified analysis (Table 4) . This was statistically significant only for systolic BP. After Bonferroni correction the association remained statistically significant. In women, whereas systolic BP increased with age for heterozygotes and major allele homozygotes of each SNP, this was not seen for the minor allele (longevity-associated) homozygotes (Supplementary Figure S1 ), consistent with a protective effect of this genotype against the usual rise in systolic BP with age.
Replication studies
The G allele of rs2802292 was associated with lower prevalence of EHT in Japanese subjects from the SONIC study (Table 5 ). Subdivision by sex was not significant, possibly because of the lower n value of the SONIC cohort. Combining SONIC data with FBPP data was precluded by the older age of the former (80 ± 1 vs. 56.6 ± 6.5 years).
In the genome-wide association studies meta-analysis of BP in European subjects, 24 T allele carriage of rs2802292, G allele carriage of rs2253310, and G allele carriage of rs2802288 tracked with significantly lower systolic BP (P = 0.0011, 0.0009, and 0.0010, respectively) and diastolic BP (P = 0.42, 0.043, and 0.044), respectively, not stratified for sex. The P values did not reach genome-wide significance.
Allele frequencies for rs2253310, rs2802288, and rs2802292 were C/G 0.425/0.575, A/G 0.425/0.575, and G/T 0.424/0.576, respectively.
DISCUSSION
The longevity-associated allele of 3 FOXO3 SNPs was associated with lower systolic and diastolic BP and EHT in Japanese American women, but not in men. The reason for the sex difference is not apparent. Since EHT is a major risk factor for myocardial infarction and stroke, these findings suggest a possible protective mechanism by which genetic variation in FOXO3 might assist in lifespan extension in women.
Although the level of statistical significance obtained was modest, the direction of the association seen was consistent for each of systolic BP, diastolic BP, and EHT in Japanese subjects. The study cohort was not selected based on a subgroup of the Honolulu Heart Program that was long-lived. Rather, offspring of all Honolulu Heart Program participants were contacted. Since related individuals were included, all data were adjusted for effect of familial clustering and only adjusted data are presented. Adjusted data nevertheless yielded results similar to unadjusted data. Confirmation in larger cohorts is required.
Replication in Japanese subjects from Japan supports the findings. But in White subjects of European descent genotypic association with systolic and diastolic BP was opposite. The reason for this is unclear, although correction for multiple testing would render the results nonsignificant. It is, however, of possible interest that although FOXO3 rs2802288 genotype is strongly associated with longevity in both Asians and Europeans, for rs2802292 the association in Europeans is weaker than in Asians. 8 The various cardiovascular actions of FoxO3 support the possibility of protection against EHT. In a twin study, the FOXO3 rs2800292 G allele was associated with more favorable insulin sensitivity and increased FOXO3 expression. 25 Mice lacking FoxO1, FoxO3, and FoxO4 in myeloid cells had a pro-atherogenesic phenotype. 26 By inhibiting vascular smooth muscle cell proliferation and neointimal hyperplasia, 27 FoxO3 reduces peripheral vascular resistance and BP. FoxO3 reduces cardiomyocyte proliferation and size, [28] [29] [30] [31] so protecting against cardiac hypertrophy seen commonly in EHT. 32 It also decreases oxidative stress in cardiac fibroblasts. 33 FoxO3 protects the kidney against aging-related damage 34 by reducing reactive oxygen species and inflammation that increase EHT risk. 35, 36 FoxO3 reduces production of inflammatory cytokines [37] [38] [39] and FOXO3 SNP rs12212067 (in linkage disequilibrium with rs2802292, rs2253310, and rs2802292) was associated with inflammation suppression. 40 Vascular aging is, in part, an inflammatory process, 41 leading to remodeling of resistance vessels. 42 Age-related loss of microvascular density and plasticity is associated with adult stem cell dysfunction in vascular niches driven, in part, by inflammatory cytokines inhibited by FoxO3. 40 FoxO3 is a primary driver of a protective autophagy program and quiescence 43 in adult cardiac stem cells, 44 helps maintain the hemopoietic stem cell pool, 45, 46 and promotes the quiescent state during stem cell self-renewal in adult muscle regeneration. 43 Regenerative stem cell survival could profoundly benefit myocardial remodeling with age.
In conclusion, longevity-associated genetic variants in FOXO3 might reduce BP and EHT in American women of Japanese ancestry. Dietary modulators of FoxO3 lower BP 47 and mitigate hypertension, reduce renal inflammation and oxidative stress, restore antioxidant capacity in the spontaneously hypertensive rats, 48 and lower systolic, but not diastolic, BP 49, 50 in type 2 diabetes patients. 49, 50 Such effects involve sirtuins, which, by modulating FoxO3 activity, regulate its transcription of genes responsible for attenuation of reactive oxygen species, 4 so ameliorating oxidative damage to tissues involved in cardiovascular control. Sirtuin activating compounds could serve as novel antihypertensive agents, with FoxO3 activation a possible mediator of part of their effect on BP.
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